ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,217,770 | -17.3% | 340,159 | -14.8% | 0.00% | 0.0% |
| Q2 2023 | $1,473,004 | +90.7% | 399,188 | +71.0% | 0.00% | 0.0% |
| Q1 2023 | $772,597 | -10.7% | 233,413 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $865,496 | +28749.9% | 223,066 | +20845.2% | 0.00% | – |
| Q3 2022 | $3,000 | – | 1,065 | +1070.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 91 | -99.7% | 0.00% | – |
| Q3 2021 | $40,000 | +25.0% | 35,000 | +91.0% | 0.00% | – |
| Q1 2021 | $32,000 | +14.3% | 18,328 | +25.2% | 0.00% | – |
| Q4 2020 | $28,000 | -48.1% | 14,634 | +20.3% | 0.00% | – |
| Q3 2019 | $54,000 | – | 12,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |